competitive cost antibiotic resistance mycobacterium tuberculosis
mathematical models predict future multidrug-resistant tuberculosis epidemic will depend fitness cost drug resistance show laboratory-derived mutants mycobacterium tuberculosis rifampin resistance universally associated competitive fitness cost cost determined specific resistance mutation strain genetic background contrast demonstrate prolonged patient treatment can result multidrug-resistant strains fitness defect strains low no-cost resistance mutations also frequent among clinical isolates
